Syncope
Conditions
Keywords
Observation Unit, Emergency Department
Brief summary
Syncope, defined as a transient loss of consciousness, accounts for over 700,000 annual U.S. emergency department visits and may herald a life-threatening condition in older adults (age≥60 years). Existing risk prediction instruments cannot reliably identify who among such older patients can safely be discharged home from an emergency department. As a result, the majority of older patients without a clear cause for syncope are hospitalized for diagnostic evaluation. However, current admission practices are characterized by low diagnostic yield, do not clearly improve outcomes, and account for over $2.4 billion in annual hospital costs. Most admitted patients are discharged within 48 hours, and approximately 50% of patients do not have an identified cause of syncope after their hospitalization. The implementation of an expedited and standardized Emergency Department Observation Syncope Protocol (EDOSP) may safely reduce hospitalization of older patients with syncope. The investigators propose a pilot randomized trial to implement and evaluate EDOSP at two emergency departments. This study has the following exploratory Specific Aims: 1. To compare admission rates and length-of-stay associated with EDOSP to standard care. 2. To compare serious outcomes rates associated with EDOSP to standard care. 3. To compare quality-of-life associated with EDOSP to standard care. 4. To compare the incremental costs and cost-effectiveness of EDOSP to standard care. Over a one-year period, 120 intermediate-risk older adults who present with syncope at the two study sites will be randomized to 1 of 2 arms: 1.) intervention arm: expedited and standardized EDOSP care; or 2.) control arm: routine care consisting of admission from the emergency department. If this pilot trial suggests that EDOSP can safely reduce admissions, then the investigators will plan a larger study powered to evaluate clinical, quality-of-life, and economic outcomes. A successful EDOSP intervention would have important clinical policy implications and improve the emergency department care of older adults with syncope.
Interventions
OTHEREmergency Department Observation Protocol
The EDOSP will consist of cardiac enzyme testing, 12-24 hours of cardiac monitoring, and echocardiogram testing by explicit criteria
OTHERUnstructured, inpatient evaluation
This is unstructured management by an inpatient medical team.
Sponsors
University of Southern California
Brigham and Women's Hospital
Corewell Health East
Duke University
National Institute on Aging (NIA)
University of California, Los Angeles
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age≥60 years * A complaint of syncope or near-syncope (Syncope is defined as a sudden, transient loss of consciousness. Near-syncope is defined as a sensation of imminent loss of consciousness, without actual syncope.) * Intermediate risk of adverse outcome (see Table) * Patient speaks either English or Spanish as a primary language.
Exclusion criteria
* Syncope mimics (intoxication, weakness or dizziness with syncope/ near-syncope, hypoglycemia, and cardiac arrest) * New or baseline cognitive impairment or dementia) * Inability to provide follow-up information (e.g. homeless or resides outside of U.S.) * Inability to speak Spanish or English * Low- and high-risk patients (see Table). Risk Stratification Guidelines: * High Risk * Serious condition identified in ED * History of ventricular arrhythmia * Cardiac Device with dysfunction * Presentation consistent with acute coronary ischemia Intermediate Risk * No High Risk features * Presentation not consistent with orthostatic or vasovagal syncope Low Risk * Presentation consistent with orthostatic or vasovagal syncope
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Admission Rate | Enrollment date |
Secondary
| Measure | Time frame |
|---|---|
| 30 day clinical outcomes | 30 days |
| Quality of life | 30 days |
| Cost | 30 Days |
Countries
United States
Outcome results
None listed